Peng Wei
Department of Biostatistics, Division of Discovery Science
Present Title & Affiliation
Primary Appointment
Co-Director, Quantitative Sciences Program, Division of Discovery Science, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston
Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston
Adjunct Faculty, Department of Statistics, Rice University, Houston
Regular Member, Department of Quantitative Sciences, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston
Adjunct Faculty, Department of Biostatistics, The University of Texas Health Science Center at Houston, Houston, Texas
Dual/Joint/Adjunct Appointment
Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston
Adjunct Professor, Department of Statistics, Rice University, Houston
Regular Member, Department of Quantitative Sciences, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston
Adjunct Professor, Department of Biostatistics, The University of Texas Health Science Center at Houston, Houston, Texas
Education & Training
Degree-Granting Education
2009 | University of Minnesota, Minneapolis, Minnesota, US, Ph.D. in Biostatistics |
2006 | University of Minnesota, Minneapolis, Minnesota, US, M.S. in Biostatistics |
2004 | Peking University, Beijing, CN, BS in Statistics |
Experience & Service
Academic Appointments
Associate Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, 2016 - 2021
Associate Professor, Department of Biostatistics, The University of Texas Health Science Center at Houston, Houston, 2015 - 2016
Assistant Professor, Department of Biostatistics, The University of Texas Health Science Center at Houston, Houston, 2009 - 2015
Administrative Appointments/Responsibilities
Co-Director of the Quantitative Sciences Program, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas, 2022 - 2026
Other Appointments/Responsibilities
Program Committee Member, STATGEN 2025: Conference on Statistics in Genomics and Genetics, ASA Section on Statistics in Genetics and Genomics, 2024 - 2025
External Reviewer for Promotion to Full Professor/Full Member, Moffitt Cancer Center, Tampa, FL, 2024 - 2024
Program Chair Elect/Program Chair, Section on Statistics in Genomics and Genetics (SSGG), American Statistical Association, 2024 - 2025
Abstract Reviewer for ASHG 2023 Annual Meeting, American Society of Human Genetics, Washington, DC, 2023 - 2023
External reviewer for promotion to Full Professor, Mayo Clinic, Rochester, 2023 - 2023
Reviewer for promotion to Associate Professor (CFA), The University of Texas MD Anderson Cancer Center, Houston, 2023 - Present
Reviewer for promotion to Full Professor (RFA), The University of Texas MD Anderson Cancer Center, Houston, 2023 - 2023
External reviewer for promotion to Associate Staff/Associate Professor, Cleveland Clinic, Cleveland, 2023 - 2023
External reviewer for promotion to Associate Investigator/Associate Professor, Kaiser Permanente Washington Health Research Institute, Seattle, 2023 - 2023
Faculty Mentor for Dr. Chong Wu, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Co-Director, Quantitative Sciences Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, 2022 - Present
External reviewer for promotion to Full Professor, Roswell Park Comprehensive Cancer Center, Buffalo, 2022 - 2022
Local Arrangements Chair, The International Biometric Society (IBS)/The Eastern North American Region (ENAR), Houston, TX, 2021 - 2022
Faculty Mentor for Dr. Suprateek Kundu, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Faculty Mentor, International Genetic Epidemiology Society, HOUSTON, 2020 - Present
Abstract Reviewer for ASHG 2020 Annual Meeting, American Society of Human Genetics, San Diego, 2020 - 2020
External reviewer for promotion to Associate Member/Associate Professor, Moffitt Cancer Center, Tampa, 2020 - 2020
External reviewer for promotion to Associate Professor with tenure, The University of Texas at Dallas, Dallas, 2015 - Present
External Grant Reviewer, Southern Methodist University, Dallas, 2014 - Present
Member, University of Houston-Downtown (UHD) Scholars Academy K-20 Development Council, Houston, 2010 - 2011
Research Assistant, Division of Hematology, Oncology and Transplantation, The University of Minnesota Medical School, Minneapolis, MN, 2005 - 2008
Research Assistant, Division of Biostatistics, The University of Minnesota, Minneapolis, MN, 2004 - 2009
Institutional Committee Activities
Member, Division of Discovery Science Pre-PTC Review Committee, 2024 - 2024
Member, Mid Tenure Track Review Committee for Dr Ziyi Li, 2023 - 2023
Chair, Mid Tenure Track Review Committee Chair for Dr Ryan Sun, 2022 - 2022
Member, GSBS Curriculum Committee, 2021 - 2022
Senator, MD Anderson Cancer Center Faculty Senate, 2021 - 2024
Committee Member, Mid Tenure Track Review Committee for Dr Min Jin Ha, 2021 - 2021
Reviewer, INTEREST Study Section, 2020 - Present
Member, UTH-MDA Population Health Research Workgroup, 2020 - Present
Voting Member, MD Anderson Data and Safety Monitoring Committee (DSMC), 2020 - Present
Committee Member, Search Committee for Associate Director, Information Services (Quantitative Research Computing), 2019 - 2019
Co-Chair, Artificial Intelligence Assistant Professor Search Committee, 2019 - Present
Committee Member, Organizing Committee for iBRIGHT 2019 Conference, 2019 - 2019
Committee Member, Mid Tenure Track Review Committee for Dr Christine Peterson, 2019 - 2019
Committee Member, MD Anderson Epidemiology Faculty Search Committee, 2018 - Present
Committee Member, GSBS Student Scholarship Committee, 2018 - 2021
Committee Member, MD Anderson Biostatistics Faculty Search Committee, 2018 - Present
Committee Member, MD Anderson Scientific Review Committee (SRC) 4, 2018 - Present
Committee Member, GSBS Quantitative Sciences Program Exam Committee, 2018 - Present
Member, UTHealth School of Public Health Faculty Diversity Subcommittee, 2015 - 2016
Chair, UTHealth School of Public Health Search Committee for Biostatistics Faculty in Big Data, 2013 - 2015
Member, UTHealth School of Public Health Biostatistics PhD Preliminary Exam Committee, 2011 - 2016
Biostatistics Department Representative, UTHealth School of Public Health Faculty Council, 2011 - 2016
Honors & Awards
Outstanding Graduate, Peking University | |
New Student Fellowship, Division of Biostatistics, University of Minnesota | |
Outstanding Research Assistant, Division of Biostatistics, University of Minnesota | |
Doctoral Dissertation Fellowship, University of Minnesota Graduate School | |
Jacob E. Bearman Student Achievement Award, Division of Biostatistics, University of Minnesota | |
ENAR Distinguished Student Paper Award, The International Biometric Society (IBS)/ Eastern North American Region (ENAR) | |
Travel Award, ENAR Workshop for Junior Researchers | |
PRIME Award for New Investigators, School of Public Health, University of Texas Health Science Center at Houston | |
Travel Award, The Fourth IMS (International Institute of Mathematical Statistics) and ISBA (International Society for Bayesian Analysis) Joint Meeting | |
Elected Alumni Member, Delta Omega Honorary Society in Public Health at The University of Minnesota School of Public Health | |
Fellow Member, International Genetic Epidemiology Society | |
Fellow, American Statistical Association (ASA) |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Seo A, Xiao W, Gjyshi O, Yoshida-Court K, Wei P, Swanson D, Napravnik TC, Grippin A, Venkatesan AM, Jacobsen MC, Fuentes DT, Lynn E, Sammouri J, Jhingran A, Joyner M, Lin LL, Colbert LE, Gillison ML, Klopp AH. Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation. Clinical Cancer Research None(None):None. e-Pub 2024. PMID: None.
- Xu Z, Wei P. A novel statistical framework for meta-analysis of total mediation effect with high-dimensional omics mediators in large-scale genomic consortia. PLOS Genetics None(None):None. e-Pub 2024. PMID: None.
- Sood A, Lim A, Yao H, Wei P, Narayan V, Lee I, Seif M, Bree K, Matulay J, Campbell M, Kamat A, Dinney C, Navai N. Is pT0 a Reliable Endpoint for Biomarker Discovery for Preoperative Chemotherapy Response in Patients with Bladder Cancer?. JU Open Plus None(None):None. e-Pub 2024. PMID: None.
- Xu Z, Li C, Chi S, Yang T, Wei P. Speeding up interval estimation for R2-based mediation effect of high-dimensional mediators via cross-fitting. Biostatistics None(None):None, 2024. PMID: 39412139.
- Sun P, Gu KJ, Zheng G, Sikora AG, Li C, Zafereo M, Wei P, Wu J, Shete S, Liu J, Li G. Genetic variations associated with telomere length predict the risk of recurrence of non-oropharyngeal head and neck squamous cell carcinoma. Mol Carcinog 63(9):1722-1737, 2024. e-Pub 2024. PMID: 38837510.
- Teo JM, Kumar VA, Lee J, Eldaya RW, Hou P, Jen ML, Noll KR, Wei P, Ferguson SD, Prabhu SS, Wintermark M, Liu HL. Probabilistic Presurgical Language fMRI Atlas of Patients with Brain Tumors. AJNR Am J Neuroradiol None(None):None, 2024. e-Pub 2024. PMID: 38889968.
- Feng H, Wu L, Zhao B, Huff C, Zhang J, Wu J, Lin L, Wei P, Wu C. Benchmarking DNA Foundation Models for Genomic Sequence Classification. bioRxiv None(None):None, 2024. PMID: 39185205.
- Yang Z, Mansour J, Sun P, Wei P, Dahlstrom KR, Zafereo M, Li G, Gross ND. Impact of pretreatment body mass index on the survival of head and neck cancer patients. Head Neck 46(8):1881-1892, 2024. e-Pub 2024. PMID: 38269627.
- Sanchez JI, Fontillas AC, Kwan SY, Sanchez CI, Calderone TL, Lee JL, Elsaiey A, Cleere DW, Wei P, Vierling JM, Victor DW, Beretta L. Metabolomics biomarkers of hepatocellular carcinoma in a prospective cohort of patients with cirrhosis. JHEP Rep 6(8):101119, 2024. e-Pub 2024. PMID: 39139459.
- Mohamed RM, Panthi B, Adrada BE, Boge M, Candelaria RP, Chen H, Guirguis MS, Hunt KK, Huo L, Hwang KP, Korkut A, Litton JK, Moseley TW, Pashapoor S, Patel MM, Reed B, Scoggins ME, Son JB, Thompson A, Tripathy D, Valero V, Wei P, White J, Whitman GJ, Xu Z, Yang W, Yam C, Ma J, Rauch GM. Multiparametric MRI-based radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Sci Rep 14(1):16073, 2024. e-Pub 2024. PMID: 38992094.
- Chi S, Flowers CR, Li Z, Huang X, Wei P. MASH: MEDIATION ANALYSIS OF SURVIVAL OUTCOME AND HIGH-DIMENSIONAL OMICS MEDIATORS WITH APPLICATION TO COMPLEX DISEASES. Ann Appl Stat 18(2):1360-1377, 2024. PMID: 39328363.
- Lee S, Bondaruk J, Wang Y, Chen H, Lee JG, Majewski T, Mullen RD, Cogdell D, Chen J, Wang Z, Yao H, Kus P, Jeong J, Lee I, Choi W, Navai N, Guo C, Dinney C, Baggerly K, Mendelsohn C, McConkey D, Behringer RR, Kimmel M, Wei P, Czerniak B. Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis. Cell Rep 43(5):114146, 2024. e-Pub 2024. PMID: 38676926.
- Czerniak B, Lee S, Jung SY, Kus P, Bondaruk J, Lee J, Jaksik R, Putluri N, Dinh K, Cogdell D, Chen H, Wang Y, Chen J, Nevai N, Dinney C, Mendelsohn C, McConkey D, Behringer R, Guo C, Wei P, Kimmel M. Inferring Bladder Cancer Evolution from Mucosal field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic Mapping. Res Sq None(None):None, 2024. e-Pub 2024. PMID: 38659962.
- Niu Z, Sun P, Zafereo ME, Liu H, Wei P, Wu J, Gross ND, Shete S, Wei Q, Zheng G, Sikora AG, Calin GA, Li G. TGF-beta1 and TGF-betaR1 variants are associated with clinical outcomes in smoking-related head and neck cancer patients treated with chemoradiation through modulating microRNA-mediated regulation. Cancer Immunol Immunother 73(5):85, 2024. e-Pub 2024. PMID: 38554185.
- Zhu H, Choi J, Kui N, Yang T, Wei P, Li D, Sun R. Identification of Pancreatic Cancer Germline Risk Variants With Effects That Are Modified by Smoking. JCO Precis Oncol 8(None):e2300355, 2024. PMID: 38564682.
- Musall BC, Rauch DE, Mohamed RMM, Panthi B, Boge M, Candelaria RP, Chen H, Guirguis MS, Hunt KK, Huo L, Hwang KP, Korkut A, Litton JK, Moseley TW, Pashapoor S, Patel MM, Reed BJ, Scoggins ME, Son JB, Tripathy D, Valero V, Wei P, White JB, Whitman GJ, Xu Z, Yang WT, Yam C, Adrada BE, Ma J. Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic Therapy. J Magn Reson Imaging None(None):None, 2024. e-Pub 2024. PMID: 38294179.
- Chen Z, Liang H, Wei P. Data-adaptive and pathway-based tests for association studies between somatic mutations and germline variations in human cancers. Genet Epidemiol 47(8):617-636, 2023. e-Pub 2023. PMID: 37822029.
- Lu Y, Wilson ZJ, Xu G, Xu Z, Pan T, Wei P. Diagnostic Performance of PSMA-Based 18F-DCFPyL PET/CT in Prostate Cancer Patients After Definitive Treatment With PSA Level =0.2 ng/mL. Clin Nucl Med 48(12):1021-1027, 2023. e-Pub 2023. PMID: 37801580.
- Xu Z, Rauch DE, Mohamed RM, Pashapoor S, Zhou Z, Panthi B, Son JB, Hwang KP, Musall BC, Adrada BE, Candelaria RP, Leung JWT, Le-Petross HTC, Lane DL, Perez F, White J, Clayborn A, Reed B, Chen H, Sun J, Wei P, Thompson A, Korkut A, Huo L, Hunt KK, Litton JK, Valero V, Tripathy D, Yang W, Yam C, Ma J. Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer. Cancers (Basel) 15(19):4829, 2023. e-Pub 2023. PMID: 37835523.
- Hebbel RP, Milbauer L, Wei P. A novel promoter of endothelial dysfunction in African Americans: Relevance to sickle cell anaemia. Br J Haematol 203(2):e71-e73, 2023. e-Pub 2023. PMID: 37485546.
- Niu Z, Sun P, Liu H, Wei P, Wu J, Huang Z, Gross ND, Shete S, Wei Q, Zafereo ME, Calin GA, Li G. Functional genetic variants in TGF-β1 and TGF-βR1 in microRNA binding sites predict outcomes in patients with HPV-positive oropharyngeal squamous cell carcinoma. Clin Cancer Res 29(16):3081-3091, 2023. e-Pub 2023. PMID: 37327315.
- Sun P, Wei P, Liu H, Wu J, Gross ND, Sikora AG, Wei Q, Shete S, Zafereo ME, Liu J, Li G. GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy. EBioMedicine 94(None):104722, 2023. e-Pub 2023. PMID: 37487414.
- Hwang KP, Elshafeey NA, Kotrotsou A, Chen H, Son JB, Boge M, Mohamed RM, Abdelhafez AH, Adrada BE, Panthi B, Sun J, Musall BC, Zhang S, Candelaria RP, White JB, Ravenberg EE, Tripathy D, Yam C, Litton JK, Huo L, Thompson AM, Wei P, Yang WT, Pagel MD, Ma J, Rauch GM. A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer. Radiol Imaging Cancer 5(4):e230009, 2023. PMID: 37505106.
- Dahlstrom KR, Sikora AG, Liu Y, Chang CC, Wei P, Sturgis EM, Li G. Characterization of the oral microbiota among middle-aged men with and without human papillomavirus infection. Oral Oncol 142:106401, 2023. e-Pub 2023. PMID: 37178654.
- El Hussein S, Medeiros LJ, Gruschkus SK, Wei P, Schlette E, Fang H, Jelloul FZ, Wang W, Fiskus W, Kanagal-Shamanna R, Loghavi S, Yang H, Li S, Xu J, Tang Z, Thakral B, Jain N, Wierda WG, Patel K, Bhalla KN, Khoury JD. Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant. Virchows Arch 482(6):1011-1019, 2023. e-Pub 2023. PMID: 36864257.
- El Hussein S, Medeiros LJ, Lyapichev KA, Fang H, Jelloul FZ, Fiskus W, Chen J, Wei P, Schlette E, Xu J, Li S, Kanagal-Shamanna R, Yang H, Tang Z, Thakral B, Loghavi S, Jain N, Thompson PA, Ferrajoli A, Wierda WG, Jabbour E, Patel KP, Dabaja BS, Bhalla KN, Khoury JD. Immunophenotypic and Genomic Landscape of Richter Transformation Diffuse Large B-cell Lymphoma. Pathology 55(4):514-524, 2023. e-Pub 2023. PMID: 36933995.
- Gregg JR, Kim J, Logothetis C, Hanash S, Zhang X, Manyam G, Muir K, Group UC, Giles GG, Stanford JL, Berndt SI, Kogevinas M, Brenner H, Eeles RA, Consortium P, Wei P, Daniel CR. Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer. Eur Urol Oncol 6(3):282-288, 2023. e-Pub 2022. PMID: 35995710.
- Panthi B, Adrada BE, Candelaria RP, Guirguis MS, Yam C, Boge M, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HC, Leung JWT, Litton JK, Mohamed RM, Musall BC, Pashapoor S, Patel MM, Perez F, Son JB, Thompson A, Valero V, Wei P, White J, Xu Z, Pinsky L, Tripathy D, Yang W, Ma J, Rauch GM. Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI. Cancers (Basel) 15(4):2023, 2023. e-Pub 2023. PMID: 36831368.
- Zhou Z, Adrada BE, Candelaria RP, Elshafeey NA, Boge M, Mohamed RM, Pashapoor S, Sun J, Xu Z, Panthi B, Son JB, Guirguis MS, Patel MM, Whitman GJ, Moseley TW, Scoggins ME, White JB, Litton JK, Valero V, Hunt KK, Tripathy D, Yang W, Wei P, Yam C, Pagel MD, Rauch GM, Ma J. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI. Sci Rep 13(1):1171, 2023. e-Pub 2023. PMID: 36670144.
- Kwan SY, Slayden AN, Coronado AR, Marquez RC, Chen H, Wei P, Savage MI, Vornik LA, Fox JT, Sei S, Liang D, Stevenson HL, Wilkerson GK, Gagea M, Brown PH, Beretta L. Treatment strategies and mechanisms associated with the prevention of NASH-associated HCC by a toll-like receptor 4 inhibitor. Cancer Prev Res (Phila) 16(1):17-28, 2023. e-Pub 2022. PMID: 36162136.
- Panthi B, Mohamed RM, Adrada BE, Boge M, Candelaria RP, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HC, Leung JWT, Litton JK, Pashapoor S, Perez F, Son JB, Sun J, Thompson A, Tripathy D, Valero V, Wei P, White J, Xu Z, Yang W, Zhou Z, Yam C, Rauch GM, Ma J. Longitudinal Dynamic Contrast-Enhanced MRI Radiomic Models for Early Prediction of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer. Front Oncol 13:1264259, 2023. e-Pub 2023. PMID: 37941561.
- Musall BC, Adrada BE, Candelaria RP, Mohamed RMM, Abdelhafez AH, Son JB, Sun J, Santiago L, Whitman GJ, Moseley TW, Scoggins ME, Mahmoud HS, White JB, Hwang KP, Elshafeey NA, Boge M, Zhang S, Litton JK, Valero V, Tripathy D, Thompson AM, Yam C, Wei P, Moulder SL, Pagel MD, Yang WT, Ma J, Rauch GM. Quantitative Apparent Diffusion Coefficients from Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer. J Magn Reson Imaging 56(6):1901-1909, 2022. e-Pub 2022. PMID: 35499264.
- Xu Y, Wang Z, Wei P, Gairola R, Kelsey KT, Sikora AG, Li G, Gu J. Hypermethylation of nc886 in HPV-positive oropharyngeal cancer and its clinical implications: An epigenome-wide association study. Mol Ther Nucleic Acids 30:596-605, 2022. e-Pub 2022. PMID: 36514351.
- Wang Z, Lu Y, Fornage M, Jiao L, Shen J, Li D, Wei P. Identification of novel susceptibility methylation loci for pancreatic cancer in a two-phase epigenome-wide association study. Epigenetics 17(11):1-16, 2022. e-Pub 2022. PMID: 35030986.
- Pankratz N, Wei P, Brody JA, Chen MH, de Vries PS, Huffman JE, Stimson MR, Auer PL, Boerwinkle E, Cushman M, de Maat MPM, Folsom AR, Franco OH, Gibbs RA, Haagenson KK, Hofman A, Johnsen JM, Kovar CL, Kraaij R, McKnight B, Metcalf GA, Muzny D, Psaty BM, Tang W, Uitterlinden AG, van Rooij JGJ, Dehghan A, O'Donnell CJ, Reiner AP, Morrison AC, Smith NL. Whole exome sequencing of 14389 individuals from the ESP and CHARGE consortia identifies novel rare variation associated with hemostatic factors. Hum Mol Genet 31(18):3120-3132, 2022. e-Pub 2022. PMID: 35552711.
- Bondaruk J, Jaksik R, Wang Z, Cogdell D, Lee S, Chen Y, Dinh KN, Majewski T, Zhang L, Cao S, Tian F, Yao H, Kus P, Chen H, Weinstein JN, Navai N, Dinney C, Gao J, Theodorescu D, Logothetis C, Guo CC, Wang W, McConkey D, Wei P, Kimmel M, Czerniak B. The origin of bladder cancer from mucosal field effects. iScience 25(7):104551, 2022. e-Pub 2022. PMID: 35747385.
- Tashakori M, Kadia T, Loghavi S, Daver N, Kanagal-Shamanna R, Pierce S, Sui D, Wei P, Khodakarami F, Tang Z, Routbort M, Bivins CA, Jabbour EJ, Medeiros LJ, Bhalla K, Kantarjian HM, Ravandi F, Khoury JD. TP53 Copy Number and Protein Expression Inform Mutation Status across Risk Categories in Acute Myeloid Leukemia. Blood 140(1):58-72, 2022. e-Pub 2022. PMID: 35390143.
- Kwan SY, Sabotta CM, Joon A, Wei P, Petty LE, Below JE, Wu X, Zhang J, Jenq RR, Hawk ET, McCormick JB, Fisher-Hoch SP, Beretta L. Gut microbiome alterations associated with diabetes in Mexican Americans in South Texas. mSystems 7(3):e0003322, 2022. e-Pub 2022. PMID: 35477306.
- Kwan SY, Jiao J, Joon A, Wei P, Petty LE, Below JE, Daniel CR, Wu X, Zhang J, Jenq RR, Futreal PA, Hawk ET, McCormick JB, Fisher-Hoch SP, Beretta L. Gut Microbiome Features Associated with Liver Fibrosis in Hispanics, a Population at High Risk for Fatty Liver Disease. Hepatology 75(4):955-967, 2022. e-Pub 2021. PMID: 34633706.
- Jimenez JE, Abdelhafez A, Mittendorf EA, Elshafeey N, Yung JP, Litton JK, Adrada BE, Candelaria RP, White J, Thompson AM, Huo L, Wei P, Tripathy D, Valero V, Yam C, Hazle JD, Moulder SL, Yang WT, Rauch GM. A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer. Eur J Radiol 149:110220, 2022. e-Pub 2022. PMID: 35193025.
- Zhou J, Jiang X, Xia HA, Wei P, Hobbs BP. Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response. Stat Med 41(4):751-768, 2022. e-Pub 2021. PMID: 34888892.
- Nguyen TT, Bhosale PR, Xu G, Pan T, Wei P, Lu Y. Comparison of PSMA-based 18F-DCFPyL PET/CT and pelvic multiparametric MRI for lesion detection in the pelvis in patients with prostate cancer. Am J Nucl Med Mol Imaging 12(6):166-179, 2022. e-Pub 2022. PMID: 36636233.
- Sabotta CM, Kwan SY, Petty LE, Below JE, Joon A, Wei P, Fisher-Hoch SP, McCormick JB, Beretta L. Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease. Front Genet 13:995488:995488, 2022. e-Pub 2022. PMID: 36386790.
- Zhou J, Jiang X, Xia HA, Hobbs BP, Wei P. Landmark mediation survival analysis using longitudinal surrogate. Front Oncol 12:999324, 2022. e-Pub 2023. PMID: 36733365.
- Wei P. Radiomics, Deep Learning and Early Diagnosis in Oncology. Emerg Top Life Sci 5(6):829-835, 2021. PMID: 34874454.
- Zhou J, Jiang X, Amy Xia H, Wei P, Hobbs BP. A Survival Mediation Model with Bayesian Model Averaging. Stat Methods Med Res 30(11):9622802211037069, 2021. e-Pub 2021. PMID: 34448657.
- Sanchez JI, Jiao J, Kwan SY, Veillon L, Warmoes MO, Tan L, Odewole M, Rich NE, Wei P, Lorenzi PL, Singal AG, Beretta L. Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila) 14(10):955-962, 2021. e-Pub 2021. PMID: 34253566.
- Zhang S, Rauch GM, Adrada BE, Boge M, Mohamed RMM, Abdelhafez AH, Son JB, Sun J, Elshafeey NA, White JB, Musall BC, Miyoshi M, Wang X, Kotrotsou A, Wei P, Hwang KP, Ma J, Pagel MD. Assessment of Early Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Using Amide Proton Transfer-weighted Chemical Exchange Saturation Transfer MRI: A Pilot Study. Radiol Imaging Cancer 3(5):e200155, 2021. PMID: 34477453.
- Jiao J, Kwan SY, Sabotta CM, Tanaka H, Veillon L, Warmoes MO, Lorenzi PL, Wang Y, Wei P, Hawk ET, Almeda JL, McCormick JB, Fisher-Hoch SP, Beretta L. Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics. Cancer Epidemiol Biomarkers Prev 30(9):1643-1651, 2021. e-Pub 2021. PMID: 34155064.
- Yang T, Jackson VE, Smith AV, Chen H, Bartz TM, Sitlani CM, Psaty BM, Gharib SA, O'Connor GT, Dupuis J, Xu J, Lohman K, Liu Y, Kritchevsky SB, Cassano PA, Flexeder C, Gieger C, Karrasch S, Peters A, Schulz H, Harris SE, Starr JM, Deary IJ, Manichaikul A, Oelsner EC, Barr RG, Taylor KD, Rich SS, Bonten TN, Mook-Kanamori DO, Noordam R, Li-Gao R, Jarvelin MR, Wielscher M, Terzikhan N, Lahousse L, Brusselle G, Weiss S, Ewert R, Gläser S, Homuth G, Shrine N, Hall IP, Tobin M, London SJ, Wei P, Morrison AC. Rare and low-frequency exonic variants and gene-by-smoking interactions in pulmonary function. Sci Rep 11(1):19365, 2021. e-Pub 2021. PMID: 34588469.
- Qin Y, Wang JR, Wang Y, Iyer P, Cote GJ, Busaidy NL, Dadu R, Zafereo M, Williams MD, Ferrarotto R, Gunn GB, Wei P, Patel K, Hofmann MC, Cabanillas ME. Clinical Utility of Circulating Cell-free DNA Mutations in Anaplastic Thyroid Carcinoma. Thyroid 31(8):1235-1243, 2021. e-Pub 2021. PMID: 33599171.
- Adrada BE, Candelaria R, Moulder S, Thompson A, Wei P, Whitman GJ, Valero V, Litton JK, Santiago L, Scoggins ME, Moseley TW, White JB, Ravenberg EE, Yang WT, Rauch GM. Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer. Cancer 127(16):2880-2887, 2021. e-Pub 2021. PMID: 33878210.
- Yang T, Niu J, Chen H, Wei P. Estimation of Total Mediation Effect for High-dimensional Omics Mediators. BMC Bioinformatics 22(414):1-17, 2021. e-Pub 2021. PMID: 34425752.
- Musall BC, Abdelhafez AH, Adrada BE, Candelaria RP, Mohamed RMM, Boge M, Le-Petross H, Arribas E, Lane DL, Spak DA, Leung JWT, Hwang KP, Son JB, Elshafeey NA, Mahmoud HS, Wei P, Sun J, Zhang S, White JB, Ravenberg EE, Litton JK, Damodaran S, Thompson AM, Moulder SL, Yang WT, Pagel MD, Rauch GM, Ma J. Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer. J Magn Reson Imaging 54(1):251-260, 2021. e-Pub 2021. PMID: 33586845.
- Shu H, Chiang T, Wei P, Do KA, Lesslie MD, Cohen EO, Srinivasan A, Moseley TW, Chang Sen LQ, Leung JWT, Dennison JB, Hanash SM, Weaver OO. A Deep-Learning Approach to Recreate Raw Full-Field Digital Mammograms for Breast Density and Texture Analysis. Radiol Artif Intell 3(4):e200097, 2021. e-Pub 2021. PMID: 34350403.
- Khan IM, Gjuka D, Jiao J, Song X, Wang Y, Wang J, Wei P, El-Serag HB, Marrero JA, Beretta L. A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila) 14(6):667-674, 2021. e-Pub 2021. PMID: 33685927.
- Fang H, Yabe M, Zhang X, Kim Y, Wu X, Wei P, Chi S, Zheng L, Garcia-Manero G, Shao L, Yuan J, Shen Y, Zheng G, Tang G, Wang W, Loghavi S, Shen Q, Yuan Y, He R, Chen D, Medeiros LJ, Hu S. Myelodysplastic Syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 Better Classified as Acute Myeloid Leukemia? A Multicenter Study of 107 Cases. Mod Pathol 34(6):1143-1152, 2021. e-Pub 2021. PMID: 33558656.
- Malec SA, Wei P, Bernstam EV, Boyce RD, Cohen T. Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance. J Biomed Inform 117:103719, 2021. e-Pub 2021. PMID: 33716168.
- Wang Z, Wei P. IMIX: A multivariate mixture model approach to association analysis through multi-omics data integration. Bioinformatics 36(22-23):5439-5447, 2021. e-Pub 2020. PMID: 33258948.
- Zhang X, Hoffman KL, Wei P, Elhor Gbito KY, Joseph R, Li F, Scheet P, Chang S, Petrosino JF, Daniel CR. Baseline oral microbiome and all-cancer incidence in a cohort of non-smoking Mexican American women. Cancer Prev Res (Phila) 14(3):383-392, 2021. e-Pub 2020. PMID: 33277317.
- Shi B, Wei P, Huang X. Functional principal component based landmark analysis for the effects of longitudinal cholesterol profiles on the risk of coronary heart disease. Stat Med 40(3):650-667, 2021. e-Pub 2020. PMID: 33155338.
- Abdelhafez AH, Musall BC, Adrada BE, Hess K, Son JB, Hwang KP, Candelaria RP, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, Arribas E, Lane DL, Scoggins ME, Leung JWT, Mahmoud HS, White JB, Ravenberg EE, Litton JK, Valero V, Wei P, Thompson AM, Moulder SL, Pagel MD, Ma J, Yang WT, Rauch GM. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Breast Cancer Res Treat 185(1):1-12, 2021. e-Pub 2020. PMID: 32920733.
- Yang T, Wei P, Pan W. Integrative analysis of multi-omics data for discovering low-frequency variants associated with low-density lipoprotein cholesterol levels. Bioinformatics 36(21):5223-5228, 2021. e-Pub 2020. PMID: 33070182.
- Yang T, Tang H, Risch HA, Olson SH, Peterson G, Bracci PM, Gallinger S, Hung RJ, Neale RE, Scelo G, Duell EJ, Kurtz RC, Khaw KT, Severi G, Sund M, Wareham N, Amos CI, Li D, Wei P. Incorporating multiple sets of eQTL weights into gene-by-environment interaction analysis identifies novel susceptibility loci for pancreatic cancer. Genet Epidemiol 44(8):880-892, 2020. e-Pub 2020. PMID: 32779232.
- Zheng J, Hoffman KL, Chen JS, Shivappa N, Sood A, Browman GJ, Dirba DD, Hanash S, Wei P, Hebert JR, Petrosino JF, Schembre SM, Daniel CR. Dietary inflammatory potential in relation to the gut microbiome: results from a cross-sectional study. Br J Nutr 124(9):1-31, 2020. e-Pub 2020. PMID: 32475373.
- Tang H, Jiang L, Stolzenberg-Solomon RZ, Arslan AA, Beane Freeman LE, Bracci PM, Brennan P, Canzian F, Du M, Gallinger S, Giles GG, Goodman PJ, Kooperberg C, Le Marchand L, Neale RE, Shu XO, Visvanathan K, White E, Zheng W, Albanes D, Andreotti G, Babic A, Bamlet WR, Berndt SI, Blackford A, Bueno-de-Mesquita B, Buring JE, Campa D, Chanock SJ, Childs E, Duell EJ, Fuchs C, Gaziano JM, Goggins M, Hartge P, Hassam MH, Holly EA, Hoover RN, Hung RJ, Kurtz RC, Lee IM, Malats N, Milne RL, Ng K, Oberg AL, Orlow I, Peters U, Porta M, Rabe KG, Rothman N, Scelo G, Sesso HD, Silverman DT, Thompson IM, Tjønneland A, Trichopoulou A, Wactawski-Wende J, Wentzensen N, Wilkens LR, Yu H, Zeleniuch-Jacquotte A, Amundadottir LT, Jacobs EJ, Petersen GM, Wolpin BM, Risch HA, Chatterjee N, Klein AP, Li D, Kraft P, Wei P. Genome-wide gene-diabetes and gene-obesity interaction scan in 8,255 cases and 11,900 controls from the PanScan and PanC4 Consortia. Cancer Epidemiol Biomarkers Prev 29(9):1784-1791, 2020. e-Pub 2020. PMID: 32546605.
- Teyateeti A, Khan B, Teyateeti A, Chen B, Bridhikitti J, Pan T, Wei P, Macapinlac HA, Lu Y. Diagnostic performance of F-18 fluciclovine PET/CT in post-radical prostatectomy prostate cancer patients with rising prostate-specific antigen level =0.5?ng/mL. Nucl Med Commun 41(9):906-915, 2020. PMID: 32796479.
- Shuai W, Lin P, Strati P, Patel KP, Routbort MJ, Hu S, Wei P, Khoury JD, You MJ, Loghavi S, Tang Z, Fang H, Thakral B, Medeiros LJ, Wang W. Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features. Blood Cancer J 10(8):86, 2020. e-Pub 2020. PMID: 32848129.
- Hebbel RP, Wei P, Milbauer L, Corban MT, Solovey A, Kiley J, Pattee J, Lerman LO, Pan W, Lerman A. Abnormal Endothelial Gene Expression Associated With Early Coronary Atherosclerosis. J Am Heart Assoc 9(14):e016134, 2020. e-Pub 2020. PMID: 32673514.
- Guo CC, Bondaruk J, Yao H, Wang Z, Zhang L, Lee S, Lee JG, Cogdell D, Zhang M, Yang G, Dadhania V, Choi W, Wei P, Gao J, Theodorescu D, Logothetis C, Dinney C, Kimmel M, Weinstein JN, McConkey DJ, Czerniak B. Assessment of luminal and basal phenotypes in bladder cancer. Sci Rep 10(1):9743, 2020. e-Pub 2020. PMID: 32546765.
- Yang G, Bondaruk J, Cogdell D, Wang Z, Lee S, Lee JG, Zhang S, Choi W, Wang Y, Liang Y, Wang G, Wang Y, Yao H, Dadhania V, Gao J, Logothetis C, Siefker-Radtke A, Kamat A, Dinney C, Theodorescu D, Kimmel M, Wei P, Guo CC, Weinstein JN, McConkey DJ, Czerniak B. Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer. iScience 23(6):101201, 2020. e-Pub 2020. PMID: 32521509.
- Wang Z, Wei P, Wei D, Cao S, Liu H, Chen L, Han X, Zhao X, Liu C, Li G, Yang J, Pan X, Lei D. Effect of upregulation of circMATR3 on the proliferation, metastasis, progression, and survival of hypopharyngeal carcinoma. J Cell Mol Med 24(8):4687-4697, 2020. e-Pub 2020. PMID: 32166857.
- Kwan SY, Jiao J, Qi J, Wang Y, Wei P, McCormick JB, Fisher-Hoch SP, Beretta L. Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican-American Population of South Texas. Hepatol Commun 4(4):555-568, 2020. e-Pub 2020. PMID: 32258950.
- Yang T, Wu C, Wei P, Pan W. Integrating DNA sequencing and transcriptomic data for association analyses of low-frequency variants and lipid traits. Hum Mol Genet 29(3):515-526, 2020. PMID: 31919517.
- Yang T, Kim J, Wu C, Ma Y, Wei P, Pan W. An Adaptive Test for Meta-analysis of Rare Variant Association Studies. Genet Epidemiol 44(1):104-116, 2020. e-Pub 2019. PMID: 31830326.
- Zhang Y, Sturgis EM, Wei P, Liu H, Wang Z, Ma Y, Liu C, Gu KJ, Wei Q, Li G. A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer. Mol Carcinog 58(12):2276-2285, 2019. e-Pub 2019. PMID: 31513313.
- Zhu Y, Xia X, Gross N, Dahlstrom KR, Gao L, Liang Z, Gao Z, Wei P, Liu C, Li G, Li Y, Chen X. Prognostic implications of human papillomavirus status and p16 expression in laryngeal squamous cell carcinoma. Head Neck 41(12):4151-4163, 2019. e-Pub 2019. PMID: 31566825.
- Chen B, Wei P, Macapinlac HA, Lu Y. Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer. Nucl Med Commun 40(9):940-946, 2019. e-Pub 2019. PMID: 31343613.
- Li D, Tang H, Wei P, Zheng J, Daniel CR, Hassan MM. Vitamin C and vitamin E Mitigate the Risk of Pancreatic Ductal Adenocarcinoma from Meat-Derived Mutagen Exposure in Adults in a Case-Control Study. J Nutr 149(8):1443-1450, 2019. e-Pub 2019. PMID: 31100111.
- Khogeer H, Rahman H, Jain N, Angelova EA, Yang H, Quesada A, Ok CY, Sui D, Wei P, Al Fattani A, Pierce S, Loghavi S, Lamb A, Hu P, Thakral B, Kanagal-Shamanna R, Jorgensen JL, Jabbour EJ, Kantarjian HM, Medeiros LJ, Khoury JD. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy. Br J Haematol 186(4):538-548, 2019. e-Pub 2019. PMID: 31115909.
- Luo X, Sturgis EM, Yang Z, Sun Y, Wei P, Liu Z, Wei Q, Li G. Lymphocyte Telomere Length Predicts Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy. Carcinogenesis 40(6):735-741, 2019. e-Pub 2019. PMID: 30721961.
- Zhang S, Wang Y, Bondaruk J, Majewski T, Yao H, Lee S, Lee JG, Cogdell D, Lotan Y, Dinney C, Wei P, Baggerly K, Czerniak B. Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test. Eur Urol Focus 5(4):664-675, 2019. e-Pub 2018. PMID: 29428551.
- Yang Z, Zhang Y, Wang X, Huang J, Guo W, Wei P, Li G, Wang Z, Huang Z, Zhang L. Putative biomarkers of malignant transformation of sinonasal inverted papilloma into squamous cell carcinoma. J Int Med Res 47(6):300060519838385, 2019. e-Pub 2019. PMID: 30991875.
- Guo CC, Majewski T, Zhang L, Yao H, Bondaruk J, Wang Y, Zhang S, Wang Z, Lee JG, Lee S, Cogdell D, Zhang M, Wei P, Grossman HB, Kamat A, Duplisea JJ, Ferguson JE, Huang H, Dadhania V, Gao J, Dinney C, Weinstein JN, Baggerly K, McConkey D, Czerniak B. Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer. Cell Rep 27(6):1781-1793.e4, 2019. PMID: 31067463.
- Ma Y, Wei P. FunSPU: a versatile and adaptive multiple functional annotation-based association test of whole-genome sequencing data. PLoS Genet 15(4):e1008081, 2019. e-Pub 2019. PMID: 31034468.
- Yang T, Chen H, Tang H, Li D, Wei P. A powerful and data-adaptive test for rare-variant-based gene-environment interaction analysis. Stat Med 38(7):1230-1244, 2019. e-Pub 2018. PMID: 30460711.
- Majewski T, Yao H, Bondaruk J, Chung W, Lee S, Lee JG, Zhang S, Cogdell D, Yang G, Choi W, Dinney C, Grossman HB, Logothetis C, Scherer SE, Guo CC, Zhang L, Wei P, Weinstein JN, Issa JP, Baggerly K, McConkey DJ, Czerniak B. Whole-organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis. Cell Rep 26(8):2241-2256.e4, 2019. PMID: 30784602.
- Ok CY, Loghavi S, Sui D, Wei P, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Tang G, Tang Z, Jorgensen JL, Luthra R, Ravandi F, Kantarjian HM, DiNardo CD, Medeiros LJ, Wang SA, Patel KP. Persistent IDH1/2 mutation in remission can predict relapse in patients with acute myeloid leukemia. Haematologica 104(2):305-311, 2019. e-Pub 2018. PMID: 30171025.
- Xu X, Liu H, Gross N, Wei D, Qian Y, Li W, Wei P, Li G, Zhang F, Yang Z, Lei D, Pan X. Overexpression of miRNA 4451 is Associated With a Poor Survival of Patients With Hypopharyngeal Cancer After Surgery With Postoperative Radiotherapy. Transl Oncol 11(5):1244-1250, 2018. e-Pub 2018. PMID: 30103154.
- Loghavi S, Sui D, Wei P, Garcia-Manero G, Pierce S, Routbort MJ, Jabbour EJ, Pemmaraju N, Kanagal-Shamanna R, Gur HD, Hu S, Zuo Z, Medeiros LJ, Kantarjian HM, Khoury JD. Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories. Blood Adv 2(15):1807-1816, 2018. PMID: 30054307.
- Tao Y, Sturgis EM, Huang Z, Wang Y, Wei P, Wang JR, Wei Q, Li G. TGFβ1Genetic Variants Predict Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy. Clin Cancer Res 24(9):2225-2233, 2018. e-Pub 2018. PMID: 29463556.
- Lu Z, Sturgis EM, Zhu L, Zhang H, Tao Y, Wei P, Wei Q, Li G. Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx. Mol Carcinog 57(3):361-369, 2018. e-Pub 2017. PMID: 29073727.
- Jiang C, Nischal H, Sun H, Li L, Cao Y, Wei P, Chang JY, Teng BB. Non-Native Conformational Isomers of the Catalytic Domain of PCSK9 Induce an Immune Response, Reduce Lipids and Increase LDL Receptor Levels. Int J Mol Sci 19(2), 2018. e-Pub 2018. PMID: 29495280.
- Quesada AE, Medeiros LJ, Desai PA, Lin P, Westin JR, Hawsawi HM, Wei P, Tang G, Seegmiller AC, Reddy NM, Yin CC, Wang W, Xu J, Miranda RN, Zuo Z, Li S. Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma. Mod Pathol 30(12):1688-1697, 2017. e-Pub 2017. PMID: 28776574.
- Xu Z, Wu C, Wei P, Pan W. A Powerful Framework for Integrating eQTL and GWAS Summary Data. Genetics 207(3):893-902, 2017. e-Pub 2017. PMID: 28893853.
- Ritchie MD, Davis JR, Aschard H, Battle A, Conti D, Du M, Eskin E, Fallin MD, Hsu L, Kraft P, Moore JH, Pierce BL, Bien SA, Thomas DC, Wei P, Montgomery SB. Incorporation of Biological Knowledge Into the Study of Gene-Environment Interactions. Am J Epidemiol 186(7):771-777, 2017. PMID: 28978191.
- McAllister K, Mechanic LE, Amos C, Aschard H, Blair IA, Chatterjee N, Conti D, Gauderman WJ, Hsu L, Hutter CM, Jankowska MM, Kerr J, Kraft P, Montgomery SB, Mukherjee B, Papanicolaou GJ, Patel CJ, Ritchie MD, Ritz BR, Thomas DC, Wei P, Witte JS. Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases. Am J Epidemiol 186(7):753-761, 2017. PMID: 28978193.
- Tang H, Wei P, Chang P, Li Y, Yan D, Liu C, Hassan M, Li D. Genetic polymorphisms associated with pancreatic cancer survival: A genome-wide association study. Int J Cancer 141(4):678-686, 2017. e-Pub 2017. PMID: 28470677.
- Hong C, Ning Y, P W, Cao Y, Chen Y. A semiparametric model for vQTL mapping. Biometrics 73(2):571-581, 2017. e-Pub 2016. PMID: 27861717.
- Simon DK, Wu C, Tilley BC, Lohmann K, Klein C, Payami H, Wills AM, Aminoff MJ, Bainbridge J, Dewey R, Hauser RA, Schaake S, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wei P, Wong PS, Yang T. Caffeine, creatine, GRIN2A and Parkinson's disease progression. J Neurol Sci 375:355-359, 2017. e-Pub 2017. PMID: 28320167.
- Zhu L, Sturgis EM, Lu Z, Zhang H, Wei P, Wei Q, Li G. Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx. Carcinogenesis 38(4):432-438, 2017. e-Pub 2017. PMID: 28334093.
- Cao Y, Rajan SS, P W. Mendelian randomization analysis of a time-varying exposure for binary disease outcomes using functional data analysis methods. Genet Epidemiol 40(8):744-755, 2016. e-Pub 2016. PMID: 27813215.
- P W, Cao Y, Zhang Y, Xu Z, Kwak IY, Boerwinkle E, Pan W. On robust association testing for quantitative traits and rare variants. G3 (Bethesda) 6(12):3941-3950, 2016. e-Pub 2016. PMID: 27678522.
- Ogunwale AN, Morrison AC, Sun W, Dodge RC, Virani SS, Taylor A, Gottesman RF, Yang E, Wei P, McEvoy JW, Heiss G, Boerwinkle E, Ballantyne CM, Nambi V. The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study. Eur J Prev Cardiol 23(14):1529-36, 2016. e-Pub 2016. PMID: 26869459.
- Xu G, Lin L, Wei P, Pan W. An adaptive two-sample test for high-dimensional means. Biometrika 103(3):609-624, 2016. PMID: None.
- Wei P, Yang Y, Guo X, Hei N, Lai S, Assassi S, Liu M, Tan F, Zhou X. Identification of an Association of TNFAIP3 Polymorphisms With Matrix Metalloproteinase Expression in Fibroblasts in an Integrative Study of Systemic Sclerosis-Associated Genetic and Environmental Factors. Arthritis Rheumatol 68(3):749-60, 2016. PMID: 26474180.
- Huang J, Wang K, Wei P, Liu X, Liu X, Tan K, Boerwinkle E, Potash JB, Han S. FLAGS: A Flexible and Adaptive Association Test for Gene Sets Using Summary Statistics. Genetics 202(3):919-29, 2016. e-Pub 2016. PMID: 26773050.
- Liu X, White S, Peng B, Johnson AD, Brody JA, Li AH, Huang Z, Carroll A, Wei P, Gibbs R, Klein RJ, Boerwinkle E. WGSA: an annotation pipeline for human genome sequencing studies. J Med Genet 53(2):111-2, 2016. e-Pub 2015. PMID: 26395054.
- Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, Odame I, Fuh B, George A, Owen W, Luchtman-Jones L, Rogers ZR, Hilliard L, Gauger C, Piccone C, Lee MT, Kwiatkowski JL, Jackson S, Miller ST, Roberts C, Heeney MM, Kalfa TA, Nelson S, Imran H, Nottage K, Alvarez O, Rhodes M, Thompson AA, Rothman JA, Helton KJ, Roberts D, Coleman J, Bonner MJ, Kutlar A, Patel N, Wood J, Piller L, Wei P, Luden J, Mortier NA, Stuber SE, Luban NL, Cohen AR, Pressel S, Adams RJ. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet 387(10019):661-70, 2016. e-Pub 2015. PMID: 26670617.
- Malec SA, Wei P, Xu H, Bernstam EV, Myneni S, Cohen T. Literature-based discovery of confounding in observational clinical data. AMIA Annu Symp Proc 2016:1920-1929, 2016. PMID: None.
- Kim T, P W. Incorporating ENCODE information into association analysis of whole genome sequencing data. BMC Proc 10(Suppl 7):257-261, 2016. e-Pub 2016. PMID: 27980646.
- Pan W, Kwak IY, P W. A Powerful Pathway-Based Adaptive Test for Genetic Association with Common or Rare Variants. Am J Hum Genet 97(1):86-98, 2015. e-Pub 2015. PMID: 26119817.
- Pan W, Chen YM, P W. Testing for polygenic effects in genome-wide association studies. Genet Epidemiol 39(4):306-16, 2015. e-Pub 2015. PMID: 25847094.
- Dong C, Wei P, Jian X, Gibbs R, Boerwinkle E, Wang K, Liu X. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum Mol Genet 24(8):2125-37, 2015. e-Pub 2014. PMID: 25552646.
- Yu B, Li AH, Muzny D, Veeraraghavan N, de Vries PS, Bis JC, Musani SK, Alexander D, Morrison AC, Franco OH, Uitterlinden A, Hofman A, Dehghan A, Wilson JG, Psaty BM, Gibbs R, Wei P, Boerwinkle E. Association of Rare Loss-Of-Function Alleles in HAL, Serum Histidine: Levels and Incident Coronary Heart Disease. Circ Cardiovasc Genet 8(2):351-5, 2015. e-Pub 2015. PMID: 25575548.
- Schick UM, Auer PL, Bis JC, Lin H, Wei P, Pankratz N, Lange LA, Brody J, Stitziel NO, Kim DS, Carlson CS, Fornage M, Haessler J, Hsu L, Jackson RD, Kooperberg C, Leal SM, Psaty BM, Boerwinkle E, Tracy R, Ardissino D, Shah S, Willer C, Loos R, Melander O, Mcpherson R, Hovingh K, Reilly M, Watkins H, Girelli D, Fontanillas P, Chasman DI, Gabriel SB, Gibbs R, Nickerson DA, Kathiresan S, Peters U, Dupuis J, Wilson JG, Rich SS, Morrison AC, Benjamin EJ, Gross MD, Reiner AP, Heart CF, Genomic Epidemiology ARI, Heart N, Lung, Sequencing Project ABIGE. Association of exome sequences with plasma C-reactive protein levels in >9000 participants. Hum Mol Genet 24(2):559-71, 2015. e-Pub 2014. PMID: 25187575.
- Cao Y, Maxwell TJ, Wei P. A family-based joint test for mean and variance heterogeneity for quantitative traits. Ann Hum Genet 79(1):46-56, 2015. e-Pub 2014. PMID: 25393880.
- Wang Y, Li D, Wei P. Powerful Tukey's One Degree-of-Freedom Test for Detecting Gene-Gene and Gene-Environment Interactions. Cancer Inform 14(Suppl 2):209-18, 2015. e-Pub 2015. PMID: 26064040.
- Sun Y, Yu W, Sturgis EM, Wei P, Lei D, Wei Q, Song X, Li G. Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck. BMC Cancer 16:70, 2015. e-Pub 2016. PMID: 26858129.
- Wei P, Tang H, Li D. Functional logistic regression approach to detecting gene by longitudinal environmental exposure interaction in a case-control study. Genet Epidemiol 38(7):638-51, 2014. e-Pub 2014. PMID: 25219575.
- Pan W, Kim J, Zhang Y, Shen X, Wei P. A powerful and adaptive association test for rare variants. Genetics 197(4):1081-95, 2014. e-Pub 2014. PMID: 24831820.
- Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen G, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PH, Khaw KT, Amos CI, Li D. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. Carcinogenesis 35(5):1039-45, 2014. e-Pub 2014. PMID: 24419231.
- Zhang C, Sturgis EM, Zheng H, Song X, Wei P, Jin L, Chao L, Wei Q, Li G. Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy. Int J Cancer 134(8):1907-15, 2014. e-Pub 2013. PMID: 24122460.
- Cao Y, Wei P, Bailey M, Kauwe JS, Maxwell TJ, Neuroimaging Initiative AD. A versatile omnibus test for detecting mean and variance heterogeneity. Genet Epidemiol 38(1):51-9, 2014. PMID: 24482837.
- Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen GM, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PH, Khaw KT, Amos CI, Li D. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Cancer Epidemiol Biomarkers Prev 23(1):98-106, 2014. e-Pub 2013. PMID: 24136929.
- Yang Y, Wei P, Guo XJ, Zhou D, Zhang WZ, Assassi S, Zhou XD. Impact of Age and Autoantibody Status on the Gene Expression of Scleroderma Fibroblasts in Response to Silica Stimulation. Eur J Inflamm 11(3):631-639, 2013. PMID: 25435887.
- Johnsen JM, Auer PL, Morrison AC, Jiao S, Wei P, Haessler J, Fox K, McGee SR, Smith JD, Carlson CS, Smith N, Boerwinkle E, Kooperberg C, Nickerson DA, Rich SS, Green D, Peters U, Cushman M, Reiner AP, Sequencing Project NE. Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project. Blood 122(4):590-7, 2013. e-Pub 2013. PMID: 23690449.
- Jin L, Sturgis EM, Zhang Y, Huang Z, Wei P, Guo W, Wang Z, Wei Q, Song X, Li G. Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck. Carcinogenesis 34(7):1551-7, 2013. e-Pub 2013. PMID: 23508638.
- Chen Y, Luo S, Chu H, Wei P. Bayesian inference on risk differences: an application to multivariate meta-analysis of adverse events in clinical trials. Stat Biopharm Res 5(2):142-155, 2013. PMID: 23853700.
- Grimes CZ, Hwang LY, Wei P, Shah DP, Volcik KA, Brown EL. Differentially regulated gene expression associated with hepatitis C virus clearance. J Gen Virol 94(Pt 3):534-42, 2013. e-Pub 2012. PMID: 23152368.
- Nischal H, Sun H, Wang Y, Ford DA, Cao Y, Wei P, Teng BB. Long-term Expression of Apolipoprotein B mRNA-specific Hammerhead Ribozyme via scAAV8.2 Vector Inhibits Atherosclerosis in Mice. Mol Ther Nucleic Acids 2:e125, 2013. e-Pub 2013. PMID: 24084845.
- Wei P, Pan W. Bayesian Joint Modeling of Multiple Gene Networks and Diverse Genomic Data to Identify Target Genes of a Transcription Factor. Ann Appl Stat 6(1):334-355, 2012. PMID: 22408712.
- Wei P, Tang H, Li D. Insights into pancreatic cancer etiology from pathway analysis of genome-wide association study data. PLoS One 7(10):e46887, 2012. e-Pub 2012. PMID: 23056513.
- Wei P, Liu X, Fu YX. Incorporating predicted functions of nonsynonymous variants into gene-based analysis of exome sequencing data: a comparative study. BMC Proc 5 Suppl 9:S20, 2011. e-Pub 2011. PMID: 22373178.
- Chen GK, Wei P, DeStefano AL. Incorporating biological information into association studies of sequencing data. Genet Epidemiol 35 Suppl 1:S29-34, 2011. PMID: 22128055.
- Wei P, Milbauer LC, Enenstein J, Nguyen J, Pan W, Hebbel RP. Differential endothelial cell gene expression by African Americans versus Caucasian Americans: a possible contribution to health disparity in vascular disease and cancer. BMC Med 9:2, 2011. e-Pub 2011. PMID: 21223544.
- Enenstein J, Milbauer L, Domingo E, Wells A, Roney M, Kiley J, Wei P, Hebbel RP. Proinflammatory phenotype with imbalance of KLF2 and RelA: risk of childhood stroke with sickle cell anemia. Am J Hematol 85(1):18-23, 2010. PMID: 19957349.
- Wei P, Pan W. Network-based genomic discovery: application and comparison of Markov random field models. J R Stat Soc Ser C Appl Stat 59(1):105-125, 2010. PMID: 21373371.
- John R, Panch S, Hrabe J, Wei P, Solovey A, Joyce L, Hebbel R. Activation of endothelial and coagulation systems in left ventricular assist device recipients. Ann Thorac Surg 88(4):1171-9, 2009. PMID: 19766802.
- Wei P, Pan W. Incorporating gene functions into regression analysis of DNA-protein binding data and gene expression data to construct transcriptional networks. IEEE/ACM Trans Comput Biol Bioinform 5(3):401-15, 2008. PMID: 18670043.
- Chang Milbauer L, Wei P, Enenstein J, Jiang A, Hillery CA, Scott JP, Nelson SC, Bodempudi V, Topper JN, Yang RB, Hirsch B, Pan W, Hebbel RP. Genetic endothelial systems biology of sickle stroke risk. Blood 111(7):3872-9, 2008. e-Pub 2007. PMID: 18156497.
- Wei P, Pan W. Incorporating gene networks into statistical tests for genomic data via a spatially correlated mixture model. Bioinformatics 24(3):404-11, 2008. e-Pub 2007. PMID: 18083717.
- Pan W, Wei P, Khodursky A. A parametric joint model of DNA-protein binding, gene expression and DNA sequence data to detect target genes of a transcription factor. Pac Symp Biocomput:465-76, 2008. PMID: 18229708.
- Li N, Wu B, Wei P, Xie B, Xie Y, Xiao G, Pan W. Functional group-based linkage analysis of gene expression trait loci. BMC Proc 1 Suppl 1:S117, 2007. e-Pub 2007. PMID: 18466458.
- Huang D, Wei P, Pan W. Combining gene annotations and gene expression data in model-based clustering: weighted method. OMICS 10(1):28-39, 2006. PMID: 16584316.
- Zang C, Guo CC, Wei P, Li Z. TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics. bioRxiv None(None):None. PMID: None.
Other Articles
- Guo CC, Lee S, Lee JG, Chen H, Zaleski M, Choi W, McConkey DJ, Wei P, Czerniak B Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nat Rev Urol 21(7):391-405, 2024. PMID: 38321289.
Abstracts
- Wang Z, Wei P. IMIX: A multivariate mixture model approach to integrative analysis of multiple types of omics data. American Society of Human Genetics (ASHG) 2020 Virtual Meeting None(None):None, 2020. PMID: None.
- Yang T, Tang H, Amos CI, Li D, P W. Incorporating multiple sets of eQTL weights into gene-by-environment interaction analysis identifies novel susceptibility loci for pancreatic cancer. International Genetic Epidemiology Society (IGES) Annual Conference 2020 130, 2020. PMID: None.
- Zhao Y, Yang T, Zhou J, Wang Z, Niu J, Chen H, Wei P. Estimation of total mediation effect for multiple types of high-dimensional omics mediators in over 3500 individuals provides novel insight into aging-related variation in blood pressure. The American Society of Human Genetics (ASHG) 2019 Annual Meeting 331, 2019. PMID: None.
- Zhao Y, Yang T, Zou J, Wang Z, Niu J, Chen H, Wei P. Estimated Total Mediation Effects for Multiple Types of High‐dimensional Omics in Over 3500 Individuals on Aging‐related Variation in Blood Pressure. International Genetic Epidemiology Society (IGES) Annual Conference 2019 138, 2019. PMID: None.
- Wang Z, Lu Y, Fornage M, Jiao L, Li D, Wei P. A Two‐stage Epigenome Wide Association Study Identifies Novel Pancreatic Cancer Susceptibility Loci by Leveraging Public Controls. International Genetic Epidemiology Society (IGES) Annual Conference 2019 120, 2019. PMID: None.
Book Chapters
- Wei P, Shu H. Big Data and Machine Learning in Oncology. In: The MD Anderson Manual of Medical Oncology. 4th Edition. McGraw Hill, 1593-1601, 2022.
Letters to the Editor
- Lee SH, Yim SY, Kim JH, Lee SS, Kaseb AO, Wei P, Lee JS. Correspondence on Letter regarding "Comprehensive Analysis of Transcriptomic Biomarkers for Predicting Response to Atezolizumab Plus Bevacizumab Immunotherapy in Hepatocellular Carcinoma.". Clin Mol Hepatol None: None, 2024.
Grant & Contract Support
Title: | High-dimensional Mediation Analysis of Cardiovascular Traits with Multi-omics Data |
Funding Source: | NIH/NHLBI |
Role: | PI |
Title: | Novel PET Imaging to Guide Therapy in Hepatocellular Carcinoma |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Real Time Metabolic Imaging to Interrogate Early Detection and Prevention of Pancreatic Cancer |
Funding Source: | Department of Defense (DOD) |
Role: | Co-I |
Title: | Quantitative Imaging of OXPHOS in Pancreatic Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Integrative modeling of spatially resolved multi-omics data to identify bladder cancer mucosal field effects |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | PI |
Title: | First-in-Human Imaging of Innate Immunity Activation with a Redox-Tuned PET Reporter |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Acquired Resistance to Therapy and Iron (ARTI) Center |
Funding Source: | NIH/NCI |
Role: | Biostatistician |
Title: | [18F]4FN PET Imaging of Innate Immunity Activation During Immunotherapy-Induced Adverse Events |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Early Detection of Hepatocellular Carcinoma |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Developing Imaging Biomarkers for Immunotherapy Resistance In Vivo |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Monitoring of Field Effects for the Detection of Bladder Cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain |
Funding Source: | NIH/NCI |
Role: | Statistician |
Title: | Impact of clonal hematopoiesis mutations on toxicity and outcomes following oncologic therapy |
Funding Source: | NIH/NCI |
Role: | Advisory Committee |
Title: | Breast Cancer PARP PET imaging Academic-Industrial Partnership to Support Regulatory Approval and Commercialization |
Funding Source: | Subaward/Subcontract via University of Pennsylvania |
Role: | Collaborator |
Title: | Quantitative PET Imaging of Hepatocellular Carcinoma (HCC) |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | MDACC-PREDICT |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma |
Funding Source: | NIH/NCI |
Role: | Biostatistics and Bioinformatics Core Co-director |
Title: | Cancer Center Support Grant (CCSG), Biostatistics Resource Group (BRG) |
Funding Source: | NIH/NCI |
Role: | Biostatistician |
Title: | Magnetic Resonance Fingerprinting of Tumor Vascular Perfusion and Acidosis |
Funding Source: | NIH/NCI subaward via Case Western Reserve University |
Role: | Co-I |
Title: | Imaging Activation of Innate Myeloid Immunity in CAR T-Cell-Associated Neurotoxicity Using [18F]4FN PET Imaging |
Funding Source: | Conquer Cancer Foundation |
Role: | Co-I |
Title: | Imaging Metabolic Reprogramming in Prostate Cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Developing a clinically relevant triaging tool for adaptive stratification of TNBC patients according to risk of residual disease after standard neoadjuvant systemic therapy |
Funding Source: | The University of Texas MD Anderson Cancer Center - Internal Funding |
Role: | Co-I |
Title: | A novel PARP inhibitor PET tracer for breast cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Targeted Inhibition of Autophagy for Treatment of Dormant Ovarian Cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | FAZA PET/CT for Monitoring Target Engagement of a Novel Complex I Inhibitor |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | SPORE in Genitourinary Cancers |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Prevention of Hepatocellular Carcinoma (HCC) Associated with Non-Alcoholic Steatohepatitis (NASH) |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Membrane Permeant Peptides for Imaging Cell Function |
Funding Source: | National Eye Institute |
Role: | Co-I |
Title: | Genomics of HCC in the Hispanic population of Texas |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Epigenetic susceptibility to pancreatic cancer |
Funding Source: | The University of Texas MD Anderson Cancer Center/IRG |
Role: | PI |
Title: | Association Analysis of Rare Variants with Sequencing Data |
Funding Source: | NIH/NHLBI via subaward University of Minnesota |
Role: | PI |
Title: | Association Analysis of Rare Variants with Sequencing Data |
Funding Source: | Sub-award University of Minnesota |
Role: | PI |
Title: | Inflammatory Response miRNAs Predict HPV-associated Oropharyngeal Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Genome-wide gene-by-smoking interaction analysis of pulmonary function |
Funding Source: | NIH via subaward The University of Texas Health Science - Houston |
Role: | Principal Investigator-MDACC |
Title: | An Integrated Genetic and Epigenetic Approach to Cerebral Small Vessel Disease |
Funding Source: | NIH/NINDS |
Role: | Co-I |
Title: | Genetic Susceptibility and Risk Model for Pancreatic Cancer |
Funding Source: | NIH/NCI |
Role: | PI |
Title: | Using Biomedical Knowledge to Identify Plausible Signals for Pharmacovigilance |
Funding Source: | NIH/NLM |
Role: | Co-I |
Title: | Impact of Amino Acid Variants and Interactions on Lipid Profiles and Incident CHD |
Funding Source: | NIH/NHLBI |
Role: | Co-I |
Title: | TCD With Transfusions Changing To Hydroxyurea – SDMC |
Funding Source: | NIH/NHLBI |
Role: | Co-I |
Title: | Statistical Methods for Finding Missing Heritability |
Funding Source: | NIH/NHLBI |
Role: | Co-I |
Title: | Systems Biology and Network Approaches to Dissecting Complex Diseases |
Funding Source: | The University of Texas Health Science Center at Houston |
Role: | PI |
Title: | Building on GWAS for NHLBI-Disease: The CHARGE Consortium |
Funding Source: | NIH/NHLBI |
Role: | Co-I |
Title: | Genetics of Hypertensive Associated Treatments (GENHAT) |
Funding Source: | NIH/NHLBI |
Role: | Co-I |
Title: | The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma |
Funding Source: | NIH/NCI |
Role: | Biostatistics and Bioinformatics Core Co-Director |
Title: | Integration of radiomic and circulating cell-free DNA methylation signatures in early detection of HPV-positive oropharyngeal cancer recurrence after initial treatment |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | NF230010: Development of biomarkers to detect malignancy in patients with NF1 |
Funding Source: | Department of Defense (DOD) |
Role: | Co-I |
Title: | Error-aware spatial subroutine approaches for spatial transcriptomics data |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Theranostic Targeting Cancer Specific Glycoprotein Expression |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Apoptotic Response Non-coding RNAs as Prognostic Predictors of HPV-Positive Oropharyngeal Cancer Patients |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Integration of radiomic and circulating cell-free DNA methylation signatures in early detection of HPV-positive oropharyngeal cancer recurrence after initial treatment |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Error-aware spatial subroutine approaches for spatial transcriptomics data |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Quantitative Immunologic PET and Diffusion MRI for Predicting Treatment Response of Esophageal Cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Co-I |
Title: | Combining Circulating Exosomes Expression with Radiomic Features for Improved Diagnosis of Cholangiocarcinoma |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Serum cell-free DNA methylation and radiomics signatures for the early detection of recurrence after initial treatment in HPV-associated oropharyngeal cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Co-I |
Title: | Glycoprotein Targeted Theranostics for Colorectal Cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Co-I |
Title: | Blood-radiomic signature for early detection of cancer recurrence after initial treatment in HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | OC220021 - Dissecting the Mechanism(s) of Statin-mediated Enhancement of Ovarian Cancer Therapy |
Funding Source: | Department of Defense (DOD) |
Role: | Statistician |
Title: | An epigenome-wide association study of apoptosis-specific noncoding RNAs in HPV-associated oropharyngeal cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | In Vivo Chemistry As A New Approach To Treat Solid Tumors |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs |
Funding Source: | NIH/NCI |
Role: | Collaborator |
Title: | Whole-Organ Spatial and Time Modeling of Mucosal Field Effects Initiating Bladder Carcinogenesis |
Funding Source: | William Marsh Rice University |
Role: | Co-PI |
Title: | Epigenome-wide study of circulating DNA methylation of HPV-associated oropharyngeal cancer and outcomes |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Reactive Embolization for Selective and Effective Treatment of Solid Tumors |
Funding Source: | NIH/NCI |
Role: | Statistician |
Title: | Quantitative and integrated immunologic and diffusion weighted imaging for predicting response to neoadjuvant chemoradiation in esophageal cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | High-dimensional Mediation Analysis of Cardiovascular Traits with Multi-omics Data |
Funding Source: | NIH/NCI |
Role: | PD/PI |
Title: | MODELING OF BLADDER CANCER EVOLUTION FROM MUCOSAL FIELD EFFECTS ON THE WHOLE-ORGAN SCALE |
Funding Source: | National Science Foundation (NSF) |
Role: | Co-PI |
Title: | Novel Radiolabeled Probes for Ovarian Cancer Imaging and Treatment |
Funding Source: | Subaward via University of Texas Rio Grange Valley School of Medicine |
Role: | Co-I |
Title: | In Vivo Chemistry As A New Approach To Treat Solid Tumors |
Funding Source: | NIH/NCI |
Role: | Statistician |
Title: | Novel PET Imaging to Guide Therapy in Hepatocellular Carcinoma |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | An epigenome-wide association study of apoptosis-specific noncoding RNAs in HPV-associated oropharyngeal cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Integration of genetics, gut microbiome environment and diet to build a risk model for hepatocellular carcinoma in subjects with non-alcoholic fatty liver disease |
Funding Source: | NIH/NCI |
Role: | Significant Contributor |
Title: | Quantitative Measurements of Tumor Perfusion and Oxygenation with Multispectral Optoacoustic Tomography |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Assessing response of esophageal cancer to chemoradiation with quantitative PET/MRI |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | PET Imaging of Immunotherapy-Induced Adverse Events |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Transforming Brain Tumor Management: "Preoperative Stereotactic Radiosurgery (SRS) Versus Postoperative SRS for Brain Metastases" |
Funding Source: | NIH/NCI |
Role: | Co-Mentor |
Title: | Metabolic Biomarkers for Immunotherapy Resistance in Melanoma |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | PA210056: Real Time Metabolic Imaging to Interrogate Early Detection and Prevention of Pancreatic Cancer |
Funding Source: | Department of Defense (DOD) |
Role: | Co-I |
Title: | Image-guided therapy for liver cancer |
Funding Source: | NIH/NCI |
Role: | Statistician |
Title: | Deep learning and biology-based mathematical models for predicting the response of triple-negative breast cancer to neoadjuvant therapy |
Funding Source: | Subaward-Subcontract via UNIVERSITY OF TEXAS AUSTIN |
Role: | Co-I |
Title: | Improving Detection of Neurotoxicity in Immunotherapies QuickFire Challenge |
Funding Source: | Johnson & Johnson |
Role: | Co-I |
Title: | Artificial intelligence of integrated radiographic and histopathological signature to improve the diagnosis of disease progression in chronic lymphocytic leukemia |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | A direct competition between deep learning and biologically-based mathematical models for predicting the response of triple negative breast cancer to neoadjuvant therapy |
Funding Source: | Subaward-Subcontract from UNIVERSITY OF TEXAS AUSTIN |
Role: | Co-I |
Title: | Quantitative Measurements of Tumor Perfusion and Oxygenation with Multispectral Optoacoustic Tomography |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | PERFECT: PERsonalized Immunotherapy For Early, Curative Treatment Of People With Triple-Negative Breast Cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Highly Specific and Potent inhibitors of the Glutamine Transporter ASCT2 as a Therapy for Colorectal Cancer |
Funding Source: | Steve Morris - AxImmune, Inc |
Role: | Co-I |
Title: | Understanding the Tumor Intrinsic and Extrinsic Roles of B7-H3 Expression in Gynecological Cancer Tumorigenesis |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Assessing response of esophageal cancer to chemoradiation with quantitative PET/MRI |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | [18F]4FN PET Imaging of Innate Immunity Activation During Immunotherapy-Induced Adverse Events |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Apoptosis-regulating non-coding RNAs as predictors of HPV16 status & outcomes of oropharyngeal cancer after radiotherapy |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Validation of Biomarkers for Bladder Cancer |
Funding Source: | NIH/NCI |
Role: | Collaborator |
Title: | Combining Heat, Hypoxia, Drugs, Resource Depletion, and Protons: A Disruptive Approach for Liver Cancer |
Funding Source: | NIH/NCI |
Role: | Statistician |
Title: | The Linear Reference Region Model Improves Dynamic Contrast Enhanced MRI for Assessing Breast Cancer Response to Treatment |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Epigenetic modifications in HPV-associated oropharyngeal squamous cell carcinoma: DNA hypermethylation of nc886 and beyond |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Coffee and Caffeine Metabolites and Disease Progression in Men Enrolled on Active Surveillance for Prostate Cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Co-I |
Title: | Integrative modeling of spatially resolved multi-omics data to identify bladder cancer mucosal field effects |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | PD/PI |
Title: | A novel mechanism of acquired resistance to ALK tyrosine kinase inhibitor therapy in lung cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Targeted therapy for NASH : a promising path to HCC prevention |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Epigenome-wide study of circulating DNA methylation of HPV-associated oropharyngeal cancer and outcomes |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Coffee and Caffeine Metabolites and Disease Progression in Men Enrolled on Active Surveillance for Prostate Cancer |
Funding Source: | Mike Slive Foundation |
Role: | Significant Contributor |
Title: | Early Detection of Hepatocellular Carcinoma |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Assessing response of esophageal cancer to chemoradiation with quantitative PET/MRI |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | PET Imaging of ROS Burst in Immune Adverse Events: First-in-Human Evaluation |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Imaging Biomarkers for Immunotherapy Resistance in Melanoma In Vivo |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Targeting Resistance to Enzalutamide Therapy in Different Metabolic Sub-types of Prostate Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | An Academic-Industrial Partnership for Preclinical Cancer Studies with NIR-II Fluorescence Imaging: Instrumentation, Contrast Agents and Applications |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Deciphering the Development of Bladder Cancer from Mucosal Field Effects |
Funding Source: | NIH/NCI |
Role: | Collaborator |
Title: | Novel Radiolabeled Probes for Ovarian Cancer Imaging and Treatment |
Funding Source: | Subaward-Subcontract from University of Texas Rio Grande Valley School of Medicine |
Role: | Co-I |
Title: | Understanding the Tumor Intrinsic and Extrinsic Roles of B7-H3 Expression in Gynecological Cancer Tumorigenesis |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy |
Funding Source: | NIH/NCI |
Role: | Core Leader |
Title: | Artificial intelligence and elucidation of biomarkers to expand liver transplantation to patients with hepatocellular carcinoma |
Funding Source: | Subaward/Subcontract via Methodist Hospital Research Institute |
Role: | Co-I |
Title: | Hyperpolarized Silicon Nanoparticles for Targeted Molecular Imaging Applications |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Cyclic Peptides for the Inhibition of Autophagy |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Imaging Biomarkers for Immunotherapy Resistance in Melanoma In Vivo |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Precise, durable treatment of liver cancer through convergence of multiple stresses |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Social, clinical and biological determinants of liver steatosis and fibrosis in Hispanics |
Funding Source: | Subaward via University of Tx Health Science Center - Houston |
Role: | Co-I |
Title: | Real Time Metabolic Imaging to Interrogate Early Detection and Prevention of Pancreatic Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Imaging Biomarkers for Early Detection and Prevention of Pancreatic Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Next Generation Embolization Strategies: Insights into Biology through Chemistry |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Hyperpolarized MR-Based Molecular Imaging for Early Detection of Precancerous and Cancerous Colorectal Lesions |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Molecular Mechanisms Initiating Bladder Carcinogenesis |
Funding Source: | NIH/NCI |
Role: | Collaborator |
Title: | Monitoring Therapeutic Intervention in Alcoholic Hepatitis By Multi-modal Imaging |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Monitoring of Field Effects for the Detection of Bladder Cancer |
Funding Source: | NIH/NCI |
Role: | Collaborator |
Title: | OC190033: Directed Evolution of Autophagy Inhibitors for the Treatment of Ovarian Cancer |
Funding Source: | Department of Defense (DOD) |
Role: | Co-I |
Title: | Artificial intelligence and elucidation of biomarkers to expand liver transplantation to hepatocellular carcinoma patients |
Funding Source: | Subaard via Methodist Hospital Research Institute |
Role: | Co-I |
Title: | Multi-modal Imaging for the Prevention of Liver Cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Diagnosis and Monitoring of Inflammation and Cell Death in NASH using PET/CT |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Blood-Based Biomarker Panel for Identifying Renal Cell Carcinoma |
Funding Source: | Department of Defense (DOD) |
Role: | Co-I |
Title: | Defining acquired mutations in normal breast tissue: association with environmental risk factors and breast cancer risk |
Funding Source: | National Comprehensive Cancer Network |
Role: | OSC |
Title: | Imaging Biomarkers for Immunotherapy Resistance in Melanoma In Vivo |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Integrating Functional Genomics and Whole Genome Sequencing Data for Venous Thromboembolism |
Funding Source: | NIH subaward via Univ of Minnesota |
Role: | PI |
Title: | Systematic Identification of Interactions between Somatic Mutations and Germline Variations in Cancer |
Funding Source: | NIH/NCI |
Role: | Collaborator |
Title: | Survival Prediction of Inflammatory Long Non-Coding RNAs in HPV-Associated Oropharyngeal Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Identification of Clinically Relevant Genomic Signatures of Lethal Variants of Bladder Cancer |
Funding Source: | NIH/NCI |
Role: | Collaborator |
Title: | Hyperpolarized Metabolic Beacons for Colorectal Cancer Detection |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Leukocyte Telomere Length as a Novel Prognostic Biomarker in Oropharyngeal Cancer patients |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Biomarkers of liver fibrosis progression in Hispanics in South Texas |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Multimodal reactive embolization: mechanism, imaging, and systemic effects |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Diet and the Gut Microbiome in Hepatocellular Carcinoma Outcomes |
Funding Source: | Department of Defense (DOD) |
Role: | Co-I |
Title: | Clinically meaningful restaging of inflammatory breast cancer with the integration of diagnostic imaging and circulating tumor cell monitoring |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Targeted Inhibition of Autophagy for Treatment of Dormant Ovarian Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Bladder Cancer Evolution from Field Effects by Whole-Organ Mapping |
Funding Source: | NIH/NCI |
Role: | Collaborator |
Title: | Multiplatform and Multianalyte Blood-Based Biomarker Discovery for the Detection of Renal Cell Carcinoma |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Co-I |
Title: | Metabolic Imaging and Inhibition in Castration Resistant Prostate Cancer |
Funding Source: | Department of Defense (DOD) |
Role: | Co-I |
Title: | Clinically meaningful restaging of stage I-III triple-negative breast cancer with the integration of diagnostic imaging and fluid-based tumor monitoring |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Real Time Metabolic Imaging to Interrogate Early Detection and Prevention of Pancreatic Cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Integrating omic data with whole genome sequencing data |
Funding Source: | NIH via Subaward The University of Minnesota |
Role: | Co-PI |
Title: | The University of Texas MD Anderson SPORE in Genitourinary Cancer |
Funding Source: | NIH/NCI |
Role: | Core B Co-Director |
Title: | Image-Guided Interventional Biology: Overwhelming Cytoprotective Stress Responses Using a New Ablation Technique |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Modeling the risk of Liver Fibrosis Progression in NASH |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Progression of hepatic fibrosis in a Mexican American community with high risk of HCC: a prospective cohort study |
Funding Source: | CPRIT via subaward UT Health Science Ctr. Houston |
Role: | Co-I |
Title: | Multimodal reactive embolization: mechanism, imaging, and systemic effects |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma - Core 2: Biostatistics and Bioinformatics |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Survival Prediction of Inflammatory Long Non-Coding RNAs in HPV-Associated Oropharyngeal Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Nanoplamonic Quantification of Tumor-Derived Extracellular Vesicles |
Funding Source: | NIH via Subaward Arizona State University |
Role: | Co-I |
Title: | Integrative Imaging of Apoptosis in Tumors |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Integrating omic data with whole genome sequencing data |
Funding Source: | NIH/NHLBI via subaward the Univ of Minnesota |
Role: | Investigator |
Title: | Measuring Extracellular pH in Pre-clinical Tumor Models with acidoCEST MRI |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Polyploid Giant Cancer Cells, Reprogramming, and Therapeutic Resistance |
Funding Source: | NIH/NCI |
Role: | Biostatistician |
Title: | Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Targeting TLR4 for NASH treatment and HCC prevention in obese subjects |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Immuno-Inflammatory Response Long Non-Coding RNAs as Prognostic Predictors of HPV-Associated Oropharyngeal Cancer Patients After Definitive Radiotherapy |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Comprehensive Molecular Characterization of Pre-Malignant Lesions in Bladder |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Modeling the risk of significant liver fibrosis in obesity and diabetes |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Co-I |
Title: | Modeling the risk of significant liver fibrosis in obesity and diabetes |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Investigator |
Title: | Measuring extracellular pH in pre-clinical tumor models with acidoCEST MRI |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Exploring the Influence of Social Media Engagement on Social Connectivity, Quality of Life and Uncertainty Among Young Adults with Advanced Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Polyploid Giant Cancer Cells, Reprogramming, and Therapeutic Resistance |
Funding Source: | NIH/NCI |
Role: | Biostatistician |
Title: | Modeling the Risk of Hepatocellular Carcinoma in Hispanics |
Funding Source: | NIH / Subaward from UT Health Science Center- Houston |
Role: | Co-I |
Title: | Exploring the Influence of Social Media Engagement on Social Connectivity, Quality of Life and Uncertainty Among Young Adults with Advanced Cancer |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Integrating omic data with whole genome sequencing data |
Funding Source: | NIH Subaward via the University of Minnesota |
Role: | PI |
Title: | Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples |
Funding Source: | Subaward Subcontract - Arizona State University |
Role: | Co-I |
Title: | Paclitaxel-Induced Reprogramming in Ovarian Cancer |
Funding Source: | Department of Defense (DOD) |
Role: | Biostatician |
Title: | Predicting effectiveness and tolerability of antidepressant therapy using large-scale observational clinical data |
Funding Source: | NIH via subaward The University of Texas Health Science Center |
Role: | PI |
Title: | Non-invasive Prognostic Telomere-associated Biomarkers in Oropharyngeal Cancer Patients |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Immuno-inflammatory Response Noncoding RNAs as Predictors of HPV16 Status and Outcomes of Oropharyngeal Cancer Patients |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Genomics for HCC Risk Assessment in Hispanics in South Texas |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Role of Senescent Polyploidy in Paclitaxel-Induced Reprogramming and Therapeutic Response |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Biostatistician |
Title: | Telomere-related Biomarkers for Risk and Prognosis Prediction of HPV-associated Oropharyngeal Cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
Title: | Exploring the influence of social media engagement on social connectivity, quality of life and uncertainty among young adults with advanced cancer |
Funding Source: | NIH |
Role: | Co-I |
Title: | Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Apoptotic Response miRNAs Predict HPV-associated Oropharyngeal Cancer Outcome |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | The University of Texas M.D. Anderson Cancer Center SPORE in Hepatocellular Carcinoma |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Prognostic Telomere-Associated Biomarkers in Oropharyngeal Cancer Patients |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Modeling The Risk For Hepatocellular Carcinoma in Hispanics |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Artificial Intelligence for Early Identification of Androgen-Indifferent, Lethal Prostate Cancer and Therapy Selection |
Funding Source: | US Department of Defense |
Role: | Co-I |
Title: | Does Alzheimer's disease sensitize subjects to chemo-brain? |
Funding Source: | US Department of Defense |
Role: | Co-I |
Title: | Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy |
Funding Source: | NIH/NCI |
Role: | Biostatistics and Bioinformatics Core Lead |
Title: | The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma |
Funding Source: | NIH/NCI |
Role: | Biostatistics and Bioinformatics Core Co-Director |
Title: | Integration of Magnetic Resonance Imaging and Blood-based Human Papillomavirus (HPV) DNA Genotyping to Predict Response to Chemoradiotherapy in Cervical Cancer (IMPACT) |
Funding Source: | NATIONAL CANCER INSTITUTE |
Role: | Co-I |
Title: | Imaging Low Frequency Features of Cell Death |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Does Aβ plaque sensitize subjects to chemo-brain? |
Funding Source: | NATIONAL INSTITUTES OF HEALTH |
Role: | Co-I |
Title: | Apoptotic Response Non-coding RNAs as Prognostic Predictors of HPV-Positive Oropharyngeal Cancer Patients |
Funding Source: | NATIONAL INSTITUTES OF HEALTH |
Role: | Co-I |
Title: | Theranostic Targeting Cancer Specific Glycoprotein Expression |
Funding Source: | NATIONAL INSTITUTES OF HEALTH |
Role: | Co-I |
Title: | Does Alzheimer's Disease Sensitize Subjects to Chemo-Brain? |
Funding Source: | NATIONAL INSTITUTES OF HEALTH |
Role: | Co-I |
Title: | Safety and Efficacy Studies of Image-Guided Reactive Embolization as a Fundamentally New Strategy to Treat Primary Liver Cancer |
Funding Source: | NATIONAL INSTITUTES OF HEALTH |
Role: | Statistican |
Title: | Serum cell-free DNA methylation and radiomics signatures for the early detection of recurrence after initial treatment in HPV-associated oropharyngeal cancer |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Co-I |
Title: | Does Alzheimer’s Disease sensitize subjects to chemo-brain? |
Funding Source: | CANCER PREVENTION RESEARCH INST OF TX |
Role: | Co-I |
Title: | Advancing prediction of postoperative neurocognitive outcomes through simulation of surgery-induced alterations in brain connectomes in patients with eloquent glioma |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Early Detection and Recurrence Monitoring of Hepatocellular Carcinoma with iCITE |
Funding Source: | NIH/NCI |
Role: | Biostatistician |
Title: | Mechanisms of Bladder Cancer Development and Its Therapeutic Vulnerabilities to Preventive and Interventive Therapy |
Funding Source: | NIH/NCI |
Role: | Biostatistics and Bioinformatics Core Lead |
Title: | Glycoprotein-targeted Radionuclide Theranostics for Pancreatic Cancer |
Funding Source: | University of Texas Rio Grange Valley School of Medicine |
Role: | Co-I |
Title: | Roles for Antigen-Presenting Cells in Immune Checkpoint Inhibitor Colitis |
Funding Source: | NIH/NCI |
Role: | Collaborator |
Title: | Transcatheter Chemistry: A Novel Approach In Image-Guided Therapy |
Funding Source: | NIH/NCI |
Role: | Biostatistics |
Title: | Association of Obesity-Related Inflammatory Cytokines on Prostate Cancer |
Funding Source: | Urology Care Foundation |
Role: | Second Mentor |
Title: | [18F]4FN PET Imaging of Innate Immunity Activation During Immunotherapy-Induced Adverse Events |
Funding Source: | NIH/NCI |
Role: | Co-I |
Title: | Breast Cancer Project 1: |
Funding Source: | The University of Texas MD Anderson Cancer Center Internal Moonshot |
Role: | Co-I |
Title: | Apoptotic Response miRNAs Predict HPV-associated Oropharyngeal Cancer Outcomes |
Funding Source: | NIH/NCI |
Role: | Co-I |
Patient Reviews
CV information above last modified November 07, 2024